CervoMed Inc. (CRVO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-51.0%

$0.80

vs $1.64 price

Levered DCF

$0.91

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

-3.92

Distress zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-2.65×	-1.16×	-9.3×	-0.68×	-1.26×	-2.67×	-0.26×	-0.35×
P/B	3.92×	0.48×	2.75×	-0.44×	0.87×	1.74×	0.15×	0.41×
P/S	0×	0×	0×	0×	0×	0×	0×	0×
EV / EBITDA	-2.34×	-0.61×	-5.76×	-2.11×	0.44×	-1.57×	0.95×	0.08×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	4.84×	11.11×	3.84×	0.32×	12.92×	7.71×	8.51×	11.09×
Debt / equity	0×	0×	0×	-1.38×	0×	0.01×	0.01×	0×
Interest coverage	0×	0×	0×	-5,920.84×	0×	0×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-148.0%	-41.6%	-29.4%	64.5%	-69.0%	-57.2%	-58.6%	-117.7%
Return on invested capital	-151.0%	-46.5%	-105.9%	-101.7%	-69.4%	-56.2%	-51.0%	-67.5%
Return on assets	-115.2%	-37.8%	-21.8%	-139.6%	-63.7%	-51.2%	-48.6%	-100.9%
Free cash flow yield	-32.8%	-87.5%	-36.7%	-65.4%	-47.9%	-31.5%	-319.6%	-167.0%
Earnings yield	-37.8%	-86.2%	-10.7%	-147.6%	-79.6%	-32.9%	-382.5%	-284.7%
Enterprise value	$63.2M	$9.9M	$12.5M	$12.3M	-$7M	$24.7M	-$10.8M	-$1.5M
Net debt / EBITDA	0.31×	0.55×	3.59×	-1.43×	2.34×	1.17×	1.23×	0.43×
Cash conversion cycle (days)	0	0	0	0	0	-1,931	-4,665	-657